INTRODUCTION
============

Crohn's disease (CD) is a chronic inflammatory intestinal disorder that involves transmural inflammation of the GI tract and can potentially cause stricture and fistula formation \[[@b1-ir-2019-09150]\]. Stricture in the small intestine is one of the most common intestinal complications and sometimes requires intestinal resection. The cumulative surgery rate after diagnosis of CD is reported to be 46%--62% at 5 years and 61%--75% at 10 years \[[@b2-ir-2019-09150]-[@b4-ir-2019-09150]\]. In addition, a greater number of strictureplasties is associated with a higher the risk of reoperation \[[@b5-ir-2019-09150]\]. To avoid the risk of short bowel syndrome, intestinal resection should be kept to a minimum \[[@b6-ir-2019-09150]\].

Endoscopic balloon dilatation (EBD) has been shown to be an effective treatment that helps to avoid surgery \[[@b7-ir-2019-09150]-[@b10-ir-2019-09150]\], and the Japanese clinical practice guidelines for IBD recommend EBD when obstructive symptoms do not improve with drug therapy alone \[[@b11-ir-2019-09150]\]. Lian et al. \[[@b12-ir-2019-09150]\] reported that EBD could delay surgery for 6.45 years in a study of 176 EBD-treated and 131 surgically treated CD patients. Although it is reported that EBD failure, strictures with fistula, long stricture, and multiple stenoses are factors that contribute to intestinal resection in CD patients with stenosis in the small intestine \[[@b13-ir-2019-09150]-[@b17-ir-2019-09150]\], there are few reports about the long-term outcomes of EBD in CD patients with strictures in the small intestine.

We were given the opportunity to use prototype single-balloon enteroscopes (SBEs) with a passive bending mechanism and high force transmission insertion tube. Colonoscopes with this mechanism and insertion tube have been reported to reduce the cecal intubation time and pain during the procedure \[[@b18-ir-2019-09150],[@b19-ir-2019-09150]\]. In a prospective study of 60 patients, the use of a prototype SBE with a passive bending mechanism and high force transmission insertion tube was found to shorten of terminal ileum intubation time compared with use of the SIF-Q260, a conventional SBE \[[@b19-ir-2019-09150]\]. However, in that study, the SBE was inserted only 20 cm from the ileocecal valve, and the results mainly reflect improvement of insertability in the colon.

We conducted this retrospective study to test our hypothesis that the prototype SBEs with a passive bending mechanism and high force transmission insertion tube can be inserted deeper than a conventional SBE in the small intestine in patients with stricturing CD who required EBD. We also analyzed whether the type of scope used affects the long-term outcomes of EBD.

METHODS
=======

1. Ethical Considerations
-------------------------

This retrospective study was approved by the Ethics Committee of Shiga University of Medical Science (approval No. R2019-121) and informed consent was waived. The study is registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000037102).

2. Patients
-----------

Among the 253 CD patients who underwent SBE at Shiga University of Medical Science from October 2005 to December 2017, we identified 94 who had undergone attempted EBD for small intestinal stenosis for inclusion in this study ([Fig. 1](#f1-ir-2019-09150){ref-type="fig"}). The 94 CD patients included 11 patients with unsuccessful EBD with failed dilation of stenosis. Disease phenotype and status was defined according to the Montreal classification \[[@b20-ir-2019-09150]\].

3. Scopes and Procedures
------------------------

Four scopes were used in this study: the SIF-Q260 (Olympus, Tokyo, Japan), which is a conventional SBE that does not have a passive bending mechanism or high force transmission insertion tube, and the SIF-Y0002, SIF-Y0007, and SIF-Y0013 (Olympus), which are prototype SBEs that have a passive bending mechanism and high force transmission insertion tube. The specifications of the scopes are shown in [Supplementary Table 1](#SD1-ir-2019-09150){ref-type="supplementary-material"}. Briefly, SIF-Y0002 is a model based on SIF-Q260 with addition of a passive bending mechanism and high force transmission insertion tube. SIF-Y0007 is a model based on SIF-Y0002 with addition of a magnifying mechanism. SIF-Y0013 is a model designed for the 290 series light source and is equipped with a passive bending mechanism, a high force transmission insertion tube, and an instrumental channel of 3.2 mm in diameter.

The endoscope was selected by the endoscopist. If both conventional and prototype scopes could be used, the prototype SBE was often selected. However, if there were multiple endoscopic examinations on the same day, they were used alternately by adjusting the cleaning time. All endoscopic procedures were performed by 3 experienced endoscopists (T.T., S.B., and K.T.).

EBD was performed using a through-the-scope balloon catheter (CRE^TM^ balloon dilatation catheter; Boston Scientific Co., Natick, MA, USA). In principle, the dilatation balloon was inflated to at least 15 mm and maintained for 30 seconds to 2 minutes. Carbon dioxide insufflation was performed during all procedures. EBD was performed under conscious sedation with midazolam or propofol.

We defined successful EBD as confirmation of dilatation of the stenosis under fluoroscopy. In patients with multiple small intestinal strictures, we defined successful EBD as confirmed dilatation of the stenosis responsible for the obstructive symptoms. Indications for EBD using SBE for small intestinal strictures at our institution include the following: no fistula or abscess in the stenosis and no untreated deep ulcer. At our institution, SBE is performed under fluoroscopic guidance to confirm the length and number of stenoses. If we find any asymptomatic stenosis that prevents passage of the scope, we perform EBD on that stenosis. Patients were hospitalized until the day after EBD and were discharged after confirming there were no symptoms such as hemorrhage and abdominal pain on the day after EBD. Procedure-related complications were defined as intestinal perforation and active bleeding requiring surgery or blood transfusion.

4. Long-term Outcome
--------------------

The long-term outcome was determined as the cumulative surgery-free rate after initial EBD. Surgery was performed for strictures that were not resolved by medical or endoscopic therapy, or for intestinal perforation as a complication of EBD. We examined whether long-term outcome was influenced by clinical background, including stenotic status, blood biochemistry, and the scope initially used. The analysis of long-term outcome included patients who were observed for at least 3 weeks after the initial EBD.

5. Insertability and Scope Used
-------------------------------

To investigate the usefulness of deep insertion of prototype SBEs with a passive bending mechanism and high force transmission insertion tube, we selected cases in which 2 or more SBE procedures were performed during the follow-up period. We then divided these cases into 3 groups according to the scope used: (1) the conventional SBE only, (2) a prototype SBE only, and (3) both conventional and prototype SBEs. For comparison of deep insertability in the small intestine, the 2 most recent procedures were compared in each group. When both the conventional and prototype SBEs were used, the most recent switching opportunity was compared. During all procedures, depth of small intestinal insertion was estimated using the method described by May et al. \[[@b21-ir-2019-09150]\]. The procedure time was defined as starting insertion of the endoscope to finishing removal of the endoscope from the patient.

6. Statistical Analyses
-----------------------

Cumulative surgery-free rates were analyzed using the Kaplan-Meier method and log-rank test. In addition, factors contributing to surgery were examined using Cox regression analysis. All variables with *P*-values less than 0.15 in univariate analysis were entered into multivariate analysis. We also included sex, age, and other factors previously described \[[@b13-ir-2019-09150]\]. Differences in insertability were analyzed using Wilcoxon's signedrank test. Statistical significance was defined as *P*\<0.05. GraphPad Prism 8.0.0 (GraphPad, San Diego, CA, USA) and SPSS version 25.0 (IBM Corp., Armonk, NY, USA) were used for statistical analysis.

RESULTS
=======

A total of 94 CD patients with a mean follow-up period of 1,886 days were included in this study. Baseline characteristics at initial EBD are shown in [Table 1](#t1-ir-2019-09150){ref-type="table"}. The mean number of EBDs performed per patient during the follow-up period was 3.3, and the mean interval between the initial EBD and the second EBD was 508 days. Among 83 patients who underwent successful EBD, 80 (96.4%) were initially dilated to more than 15 mm. Of the remaining 3 patients, 1 was initially dilated to 12 mm and 2 were initially dilated to 10 mm.

The EBD success rate was 88.3% (83/94). The 5- and 10-year cumulative surgery-free rate was 75.7% and 72.8%, respectively ([Fig. 2A](#f2-ir-2019-09150){ref-type="fig"}). [Table 2](#t2-ir-2019-09150){ref-type="table"} shows the results of multivariate analysis of factors contributing to intestinal resection. Elevated CDAI, long stenosis (≥2 cm), and EBD failure were identified as factors contributing to intestinal resection. The results were also confirmed by Kaplan-Meier analysis ([Fig. 2B](#f2-ir-2019-09150){ref-type="fig"}-[D](#f2-ir-2019-09150){ref-type="fig"}). Factors such as prototype scope used for initial EBD, number of stenoses, and *de novo* stenosis were not associated with intestinal resection. In addition, the risk of surgery increased by 2.53 times when the length of stenosis increased by 1 cm in a successful EBD case (HR, 2.53; 95% CI, 1.580--4.069; *P*\<0.001).

During the follow-up period, 314 EBDs were performed in 94 CD patients, and 4 patients (1.29%, 4/314) had intestinal perforation as a complication. There were no cases of bleeding requiring surgery or blood transfusion.

The insertability and the scope used were compared between the groups shown in [Table 3](#t3-ir-2019-09150){ref-type="table"}. We compared depth of insertion, procedure time, and number of EBDs between 2 procedures in the same patient at different times ([Fig. 3](#f3-ir-2019-09150){ref-type="fig"}). Compared with conventional SBE, prototype SBE has significantly improved the depth of insertion ([Fig. 3C](#f3-ir-2019-09150){ref-type="fig"}). A representative case is shown in [Fig. 4](#f4-ir-2019-09150){ref-type="fig"}. Use of the prototype SBE improved the depth of insertion and increased the number of EBDs.

DISCUSSION
==========

The prototype SBEs with a passive bending mechanism and high transmission insertion tube did not affect long-term EBD outcome, but they did contribute to improving the depth of insertion in the small intestine compared with the conventional SBE. This is the first study to show that prototype SBEs with this mechanism and insertion tube improve insertability in the strictured small intestine.

The EBD success rate in this study was 88.3%, which is consistent with the 62% to 100% success rate reported in a pooled analysis and meta-analyses \[[@b10-ir-2019-09150],[@b22-ir-2019-09150],[@b23-ir-2019-09150]\]. Our 5- and 10-year cumulative surgery-free survival rate of 75.7% and 72.8%, respectively, was equivalent to the 3-year rate of 73% reported by Hirai et al. \[[@b16-ir-2019-09150]\] and are slightly better than the 1- and 3-year survival rates of 63.1% and 56.2%, respectively reported by Nishida et al. \[[@b13-ir-2019-09150]\]. At our institution, patients who undergo EBD typically repeat procedures every 1 to 2 years for surveillance and evaluation regardless of the presence or absence of stenotic symptoms. In fact, 23 of the 94 patients (24.4%) had asymptomatic stenosis. The patients reported by Nishida et al. \[[@b13-ir-2019-09150]\] had stenotic symptoms, which may be the reason for the differences in results.

In an EBD study involving strictures in both small and large intestine, it was reported that the HR for intestinal resection increased by 8% when the length of stenosis increased by 1 cm. \[[@b10-ir-2019-09150]\]. In our study, an increase in the length of stenosis in the small intestine by 1 cm increased intestinal resection by 2.53 times. Our results suggest that increased length of stenosis in the small intestine may require more intestinal resection than increased length of stenosis in the colon.

Multivariate analysis revealed that long stricture (≥2 cm), EBD failure, and elevated CDAI were factors contributing to intestinal resection of small intestinal stricture. Long stricture (≥2 cm) \[[@b17-ir-2019-09150]\] and EBD failure16 have already been reported as factors contributing to intestinal resection. Although elevated CDAI has been shown to be associated with intestinal resection in CD, \[[@b24-ir-2019-09150]\] these cohorts comprised 23% (20/86) colonic stenosis and 8% (7/86) upper GI stenosis. Therefore, the novel finding in this study is that the elevated CDAI could be related to intestinal resection even in a cohort limited to the small intestine.

Until now, there have been no reports on achieving deep insertion in the small intestine using a prototype SBE with a passive bending mechanism and high force transmission insertion tube. Although Hosoe et al. \[[@b19-ir-2019-09150]\] reported that the rate of insertion to the terminal ileum 20 cm beyond the ileocecal valve within 10 minutes was improved from 86.2% to 96.8% by using a prototype SBE in a prospective study, the deep insertability in the small intestine has not been studied. Our findings indicate that the depth of insertion can be significantly improved by using these prototype SBEs in patients with stricturing CD.

The prototype SBEs did not contribute to the cumulative surgery-free survival rate (data not shown). Depth of insertion was increased with the prototype SBEs compared with the conventional SBE, but this difference did not directly improve the approach to stenosis located deep in the small intestine. In fact, the prototype SBEs did not increase the number of EBDs compared with the conventional SBE (2.1±1.8 vs. 1.9±1.4) ([Fig. 3I](#f3-ir-2019-09150){ref-type="fig"}). However, there appeared to be some cases where stenosis could be approached using only a prototype SBE, so further accumulation of cases is necessary in the future.

There are some limitations to this study. First, this is a non-randomized retrospective study. Therefore, the procedure time during insertion in the small intestine was not recorded. Because the procedure time includes the time of insertion in the large intestine, duration of EBD, and observation period, it was not possible for us to analyze the insertion time in the small intestine. Second, depth of insertion was measured using the method described by May et al., \[[@b21-ir-2019-09150]\] but this method may be less accurate than the method using crystal violet reported by Takenaka et al. \[[@b25-ir-2019-09150]\]. Third, the timing of the procedures compared to analyze the insertability was different although these procedures were performed in the same patient. Therefore, the condition of the patient may have changed. Generally, the pathology of CD is progressive, so insertion of the enteroscope becomes increasingly difficult as intestinal deformity progresses. It should be noted that the insertability improved even though most of the procedures with a prototype SBE were performed later than those with the conventional SBE.

In conclusion, the prototype SBEs with a passive bending mechanism and high force transmission insertion tube did not improve long-term EBD prognosis, but they did improve the depth of insertion compared with a conventional SBE. In addition, elevated CDAI was identified as a factor contributing to intestinal resection even in a cohort limited to CD patients with strictures in the small intestine.
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SUPPLEMENTARY MATERIALS
=======================

Supplementary materials are available at the Intestinal Research website (<https://www.irjournal.org>).

Supplementary Table 1. Enteroscope Specifications

![Study participants. Among 253 CD patients who underwent single-balloon enteroscopy (SBE), 94 underwent attempted endoscopic balloon dilatation (EBD) for small intestinal stenosis. The clinical characteristics of these 94 patients are shown in Table 1. To compare the insertability, patients who underwent SBE at least twice during the observation period were extracted and divided into 3 groups: conventional SBE only, prototype SBE only, and both conventional and prototype SBEs. Detailed information of these groups is shown in Table 3.](ir-2019-09150f1){#f1-ir-2019-09150}

![Cumulative surgery-free survival rate. Kaplan-Meier curves depicting cumulative surgery-free survival for all patients (A), and stratified by CDAI (B), stricture length (C), and endoscopic balloon dilatation (EBD) success (D). *P*-values for each curve were calculated using the log-rank test.](ir-2019-09150f2){#f2-ir-2019-09150}

![Insertability and scope used. Patients who underwent single-balloon enteroscopy (SBE) at least twice during the observation period were extracted and divided into 3 groups according to the scope used: (A, D, G) conventional SBE only; (B, E, H) prototype SBE only; and (C, F, I) both conventional and prototype SBEs. For comparison of deep insertability into the small intestine, the 2 most recent procedures were compared in the conventional SBE only group and the prototype SBE only group. The most recent switching opportunity was compared in the group that underwent both conventional and prototype SBE. For each group, depth of insertion (A-C), procedure time (D-F), and number of endoscopic balloon dilatations (G-I) were compared using Wilcoxon's signed-rank test.](ir-2019-09150f3){#f3-ir-2019-09150}

![Representative case. X-ray images at the time of endoscopic balloon dilatation (EBD) at different time points in the same patient. Depth of insertion and the number of EBDs were increased when using single-balloon enteroscopy (SBE) with a passive bending mechanism and high force transmission insertion tube. (A) Conventional SBE: depth of insertion (70 cm) and number of EBDs (n=2). (B) Prototype SBE: depth of insertion (120 cm) and number of EBDs (n=8).](ir-2019-09150f4){#f4-ir-2019-09150}

###### 

Clinical Background of the Patients

  Characteristic                                Value (n = 94)
  --------------------------------------------- ----------------
  Sex (male/female)                             77/17
  Age at diagnosis (yr)                         28.8 ± 13.0
  Age at first EBD (yr)                         37.0 ± 12.4
  BMI (kg/m^2^)                                 21.3 ± 3.3
  Smoking (yes/no)                              13/81
  Age at diagnosis (A1/A2/A3)                   8/72/14
  Disease phenotype at first EBD (B1/B2/B3)     16/62/16
  Disease location at first EBD (L1/L3)         52/42
  Perianal lesion present (yes/no)              30/64
  History of surgery (yes/no)                   48/46
  Success of EBD (yes/no)                       83/11
  Symptoms of obstruction before EBD (yes/no)   71/23
  Serum albumin (g/dL)                          3.8 ± 0.5
  Serum CRP (mg/dL)                             0.6 ± 1.0
  CDAI at first EBD (point)                     127.3 ± 76.8
  Concomitant treatments                        
   Thiopurine (yes/no)                          29/65
   Anti-TNF-α antibody (yes/no)                 43/51
  Scope used for initial EBD                    
   Conventional SBE                             44
   Prototype SBE                                50
  Stricture site                                
   Single (%)                                   49
   Multiple (%)                                 45
    2                                           22
    3                                           11
    ≥4                                          12
   *De novo* type of strictures (yes/no)        77/17
   Stricture length (cm)                        1.3 ± 0.9
   Long stricture (≥ 2 cm, yes/no)              26/68

Values are presented as mean±SD.

EBD, endoscopic balloon dilatation; A1, ≤16 years; A2, 17--40 years; A3, \>40 years; B1, non-stricturing, non-penetrating; B2, stricturing; B3, penetrating; L1, ileal; L3, ileocolonic; SBE, single-balloon enteroscopy.

###### 

Factors Associated with Intestinal Resection for all CD Patients

  Factor                          Univariate analysis      Multivariate analysis                                                           
  ------------------------------- ------------------------ ------------------------------------------------------ ------------------------ ---------------------------------------------------------
  Male sex                        0.830 (0.304--2.267)     0.715                                                  0.560 (0.171--1.837)     0.339
  Age at diagnosis                0.987 (0.947--1.028)     0.506                                                  0.994 (0.949--1.042)     0.813
  BMI                             0.989 (0.867--1.128)     0.861                                                  \-                       
  Smoking                         0.867 (0.255--2.949)     0.820                                                  \-                       
  Disease phenotype B2            0.840 (0.348--2.029)     0.698                                                  \-                       
  Disease location L1             1.555 (0.644--3.753)     0.328                                                  \-                       
  Perianal lesion present         1.615 (0.679--3.84)      0.279                                                  \-                       
  History of surgery              1.807 (0.728--4.483)     0.202                                                  3.598 (0.827--15.663)    0.088
  Failure of EBD                  18.927 (7.445--48.116)   0.001^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^   17.276 (3.546--84.159)   \< 0.001^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^
  Symptomatic bowel obstruction   2.118 (0.624--7.195)     0.230                                                  \-                       
  Serum albumin (mg/dL)           0.693 (0.287--1.674)     0.415                                                  \-                       
  Serum CRP (mg/dL)               1.287 (0.920--1.800)     0.142                                                  1.008 (0.646--1.572)     0.974
  CDAI                            1.011 (1.005--1.016)     0.001^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^   1.007 (1.000--1.014)     0.039^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^
  Use of thiopurines              0.535 (0.180--1.591)     0.261                                                  \-                       
  Use of anti-TNF-α antibody      1.622 (0.683--3.851)     0.274                                                  \-                       
  Prototype SBE                   1.652 (0.677--4.027)     0.270                                                  \-                       
  EBD for multiple strictures     0.554 (0.224--1.374)     0.203                                                  0.374 (0.111--1.265)     0.114
  De novo type of strictures      1.141 (0.383--3.407)     0.814                                                  \-                       
  Long stricture (≥ 2 cm)         11.258 (4.109--30.845)   0.001^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^   4.737 (1.290--17.388)    0.019^[a](#tfn1-ir-2019-09150){ref-type="table-fn"}^

Significant factor.

B2, stricturing; L1, ileal; EBD, endoscopic balloon dilatation; SBE, single-balloon enteroscopy.

###### 

Clinical Background of the Patients

  Characteristic                                Conventional SBE only (n = 6)   Prototype SBE only (n = 31)   Conventional and prototype SBE (n = 26)
  --------------------------------------------- ------------------------------- ----------------------------- -----------------------------------------
  Sex (male/female)                             4/2                             27/4                          19/7
  Age at diagnosis (yr)                         32.3 ± 17.1                     26.7 ± 11.0                   29.1 ± 9.8
  Age at first EBD (yr)                         40.5 ± 15.5                     36.3 ± 12.3                   38.3 ± 7.6
  BMI (kg/m^2^)                                 21.3 ± 3.8                      20.8 ± 3.1                    21.3 ± 3.1
  Smoking (yes/no)                              0/6                             5/26                          4/22
  Conventional → prototype                      \-                              \-                            23
  Prototype → conventional                      \-                              \-                            3
  Age at diagnosis (A1/A2/A3)                   1/4/1                           3/25/3                        1/22/3
  Disease phenotype at first EBD (B1/B2/B3)     0/6/0                           3/23/5                        1/20/5
  Disease location at first EBD (L1/L3)         3/3                             19/12                         17/9
  Perianal lesion (yes/no)                      0/6                             14/17                         5/21
  History of surgery (yes/no)                   3/3                             16/15                         15/11
  Success of EBD (yes/no)                       5/1                             29/2                          26/0
  Symptoms of obstruction before EBD (yes/no)   6/0                             20/11                         24/2
  Interval period (day)                         353.8 ± 188.9                   625.7 ± 440.1                 847.8 ± 765.9
  Concomitant treatments                                                                                      
   Any thiopurine (yes/no)                      2/0                             13/18                         6/18
   Anti-TNF-α antibody (yes/no)                 2/0                             15/16                         14/12
  Stricture site                                                                                              
   Single (%)                                   4                               17                            13
   Multiple (%)                                 2                               14                            13
    2                                           1                               5                             6
    3                                           1                               7                             4
    ≥4                                          0                               2                             3

Values are presented as mean±SD.

SBE, single-balloon enteroscopy; EBD, endoscopic balloon dilatation; A1, ≤16 years; A2, 17--40 years; A3, \>40 years; B1, non-stricturing, non-penetrating; B2, stricturing; B3, penetrating; L1, ileal; L3, ileocolonic.

[^1]: These authors contributed equally to this study.
